Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome After COVID-19

NCT ID: NCT06004362

Last Updated: 2024-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-04

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Post-COVID syndrome is a COVID-19 sequelae disease with high individual burden. We conduct a prospective, two-arm, randomized-controlled intervention study with embedded qualitative and physiological sub-studies in a mixed-methods design.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-COVID Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Complementary and Integrative Medicine online intervention, routine care and book

Group Type EXPERIMENTAL

Complementary and Integrative Medicine online intervention, routine care and book

Intervention Type BEHAVIORAL

The online program takes place in a multiprofessionally guided online group setting once a week for up to 180 minutes (including several breaks) over a period of 10 weeks:

* Basic principles of a plant-based whole-food nutrition
* Procedures of hydrotherapy according to Kneipp
* Self-help strategies (e.g. teas, wraps, compresses etc.)
* Methods of mind-body medicine (mindfulness, meditation, breathing, yoga etc.)
* Methods of extended Complementary and Integrative Medicine (e.g. acupressure)

It is recommended to practice a part of the taught exercises at home for about 30 minutes daily. In addition, the patients receive a book for the treatment of post-covid syndrome complaints. Group 1 additionally uses the already existing routine care (e.g. general practitioner).

Routine care and book

Group Type ACTIVE_COMPARATOR

Routine care and book

Intervention Type BEHAVIORAL

Participants in the second study arm receive routine care, e.g. from their general practitioner. In addition, the patients receive the same book as group 1 for the treatment of post-covid syndrome complaints. The participants of the second study arm will be offered to participate in the Complementary and Integrative Medicine online intervention after 4 months within the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Complementary and Integrative Medicine online intervention, routine care and book

The online program takes place in a multiprofessionally guided online group setting once a week for up to 180 minutes (including several breaks) over a period of 10 weeks:

* Basic principles of a plant-based whole-food nutrition
* Procedures of hydrotherapy according to Kneipp
* Self-help strategies (e.g. teas, wraps, compresses etc.)
* Methods of mind-body medicine (mindfulness, meditation, breathing, yoga etc.)
* Methods of extended Complementary and Integrative Medicine (e.g. acupressure)

It is recommended to practice a part of the taught exercises at home for about 30 minutes daily. In addition, the patients receive a book for the treatment of post-covid syndrome complaints. Group 1 additionally uses the already existing routine care (e.g. general practitioner).

Intervention Type BEHAVIORAL

Routine care and book

Participants in the second study arm receive routine care, e.g. from their general practitioner. In addition, the patients receive the same book as group 1 for the treatment of post-covid syndrome complaints. The participants of the second study arm will be offered to participate in the Complementary and Integrative Medicine online intervention after 4 months within the study.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute SARS-CoV2 infection at least 12 weeks ago (documented by PCR test results or SARS-CoV-2 antibodies)
* History of chronic fatigue (after SARS-CoV-2 infection)
* At least 3 of 7 criteria fulfilled at the time of inclusion: sleep disturbance, headache, joint pain/muscle pain, anxiety/depression, memory impairment/concentration disturbance, postexertional malaise, dysosmia/anosmia
* Numerical Rating Scale (NRS, 0-10 points, 0 = not able to exercise at all; 10 = full exercise capacity) physical exercise capacity of max. 6 points ("What is your physical exercise capacity on average over the last 7 days?")
* Short Form-36 Physical Function Subscale (SF-36 PFS) of maximum 65 points
* Patient are technically equipped enough to participate in the online intervention and willing to follow the study procedure to perform the online intervention at home


* Family physicians and general practitioners
* Regular outpatient care of patients with post-covid syndrome
* Willingness in principle to participate in a 2-hour interview on-site or online

Exclusion Criteria

* Fatigue already present before SARS-CoV-2 infection
* Presence of severe post-exertional malaise (PEM) (according to DSQ-PEM tool question 7 OR 8 with yes AND \>14h condition worsening)
* Other underlying conditions leading to symptoms of chronic fatigue, such as unstable mental illness, oncological disease(s), MS, fibromyalgia, and substance abuse
* Other serious underlying medical conditions, such as severe pulmonary, cardiac, psychiatric, or infectious diseases that could interfere with study participation or affect results • Ongoing opioid therapy or opioid therapy in the week prior to study entry
* Regular use of cannabinoids or other illicit drugs in the month prior to or during the study
* Restarting or discontinuing psychotherapy during study participation in the 6 weeks prior to study entry
* Pregnancy or breastfeeding
* Participation in another clinical intervention study during study participation 1
* Regular use of Complementary and Integrative Medicine self-help measures (e.g. meditation, Kneipp hydrotherapiy, etc.) within the study period
* Current pension procedure or planned claiming of a pension procedure due to disability
* Planned rehabilitation measures during study participation due to post-COVID syndrome



• No previous care of post-covid patients
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Charite University, Berlin, Germany

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andreas Michalsen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus

Berlin, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Miriam Rösner

Role: CONTACT

004980505682

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Miriam Rösner, Study nurse

Role: primary

00493080505682

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NHKOnline

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.